128 related articles for article (PubMed ID: 14520373)
1. Beta-receptor polymorphisms: heart failure's crystal ball.
Kass DA
Nat Med; 2003 Oct; 9(10):1260-2. PubMed ID: 14520373
[No Abstract] [Full Text] [Related]
2. Mechanisms of disease: beta-adrenergic receptors--alterations in signal transduction and pharmacogenomics in heart failure.
Feldman DS; Carnes CA; Abraham WT; Bristow MR
Nat Clin Pract Cardiovasc Med; 2005 Sep; 2(9):475-83. PubMed ID: 16265588
[TBL] [Abstract][Full Text] [Related]
3. Beta 1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure.
Mialet Perez J; Rathz DA; Petrashevskaya NN; Hahn HS; Wagoner LE; Schwartz A; Dorn GW; Liggett SB
Nat Med; 2003 Oct; 9(10):1300-5. PubMed ID: 14502278
[TBL] [Abstract][Full Text] [Related]
4. What is the role of beta-adrenergic signaling in heart failure?
Lohse MJ; Engelhardt S; Eschenhagen T
Circ Res; 2003 Nov; 93(10):896-906. PubMed ID: 14615493
[TBL] [Abstract][Full Text] [Related]
5. Cellular basis for therapeutic choices in heart failure.
Opie LH
Circulation; 2004 Oct; 110(17):2559-61. PubMed ID: 15505109
[No Abstract] [Full Text] [Related]
6. Regulation of beta-adrenoceptor signaling in cardiac function and disease.
Dzimiri N
Pharmacol Rev; 1999 Sep; 51(3):465-501. PubMed ID: 10471415
[No Abstract] [Full Text] [Related]
7. Genes and acquired disease: beta-adrenoceptor polymorphisms and heart failure.
Mahon NG; Mckenna WJ
Eur Heart J; 2000 Nov; 21(22):1810-2. PubMed ID: 11052848
[No Abstract] [Full Text] [Related]
8. Genetic manipulation of myocardial beta-adrenergic receptor activation and desensitization.
Hata JA; Williams ML; Koch WJ
J Mol Cell Cardiol; 2004 Jul; 37(1):11-21. PubMed ID: 15242731
[TBL] [Abstract][Full Text] [Related]
9. Association of beta-adrenergic receptor polymorphisms and progression to heart failure in patients with idiopathic dilated cardiomyopathy.
Forleo C; Resta N; Sorrentino S; Guida P; Manghisi A; De Luca V; Romito R; Iacoviello M; De Tommasi E; Troisi F; Rizzon B; Guanti G; Rizzon P; Pitzalis MV
Am J Med; 2004 Oct; 117(7):451-8. PubMed ID: 15464701
[TBL] [Abstract][Full Text] [Related]
10. American Association for the Advancement of Science meeting. DNA tells story of heart drug failure.
Couzin J
Science; 2005 Feb; 307(5713):1191. PubMed ID: 15731420
[No Abstract] [Full Text] [Related]
11. Genetic polymorphisms of the beta-adrenergic system: association with essential hypertension and response to beta-blockade.
Filigheddu F; Reid JE; Troffa C; PinnaParpaglia P; Argiolas G; Testa A; Skolnick M; Glorioso N
Pharmacogenomics J; 2004; 4(3):154-60. PubMed ID: 15069461
[No Abstract] [Full Text] [Related]
12. Genetic and phenotypic targeting of beta-adrenergic signaling in heart failure.
Koch WJ
Mol Cell Biochem; 2004 Aug; 263(1-2):5-9. PubMed ID: 15524162
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of G protein-coupled receptors: GPCR kinases in heart disease.
Hata JA; Koch WJ
Mol Interv; 2003 Aug; 3(5):264-72. PubMed ID: 14993440
[TBL] [Abstract][Full Text] [Related]
14. beta1-Adrenergic receptor polymorphisms influence the response to metoprolol monotherapy in patients with essential hypertension.
Liu J; Liu ZQ; Yu BN; Xu FH; Mo W; Zhou G; Liu YZ; Li Q; Zhou HH
Clin Pharmacol Ther; 2006 Jul; 80(1):23-32. PubMed ID: 16815314
[TBL] [Abstract][Full Text] [Related]
15. Beta-adrenergic receptors in heart failure.
Engelhardt S
Heart Fail Clin; 2005 Jul; 1(2):183-91. PubMed ID: 17386845
[No Abstract] [Full Text] [Related]
16. [Genetic polymorphism of beta-adrenergic receptors and mortality in ischemic heart disease].
Jaillon P; Simon T
Therapie; 2007; 62(1):1-7. PubMed ID: 17374341
[TBL] [Abstract][Full Text] [Related]
17. Manipulating cardiac contractility in heart failure: data from mice and men.
Dorn GW; Molkentin JD
Circulation; 2004 Jan; 109(2):150-8. PubMed ID: 14734503
[No Abstract] [Full Text] [Related]
18. Endogenous urea as an autacoid: extrarenal and renal focuses.
Temnyalov ND
Auton Neurosci; 2008 Feb; 138(1-2):1-8. PubMed ID: 18037357
[TBL] [Abstract][Full Text] [Related]
19. Targeted inhibition of beta-adrenergic receptor kinase-1-associated phosphoinositide-3 kinase activity preserves beta-adrenergic receptor signaling and prolongs survival in heart failure induced by calsequestrin overexpression.
Perrino C; Naga Prasad SV; Patel M; Wolf MJ; Rockman HA
J Am Coll Cardiol; 2005 Jun; 45(11):1862-70. PubMed ID: 15936620
[TBL] [Abstract][Full Text] [Related]
20. Blockade of beta-adrenergic signaling does not influence the bone mechano-adaptive response in mice.
Marenzana M; De Souza RL; Chenu C
Bone; 2007 Aug; 41(2):206-15. PubMed ID: 17543595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
